Frequent. Fast. Cheap. Easy.

Chosen by an independent panel of judges, the grand prize winning solutions are radically affordable compared to what is currently available on the market; and are comparable to commercial offerings at measuring sensitivity, specificity and limit of detection, with a maximum turnaround time of 12 hours from sample to result.

The winning teams are:

Reliable LFC, LLC

Antigen Testing
Carlsbad, United States

ChromaCode

RNA Testing
Carlsbad, United States

Mirimus

RNA Testing
Brooklyn, United States

La Jolla Institute for Immunology

RNA Testing
La Jolla, United States

Alveo Technologies

RNA Testing
Alameda, United States

Additionally, four other teams were selected as winners in the Open Innovation Track, whose approaches demonstrated high potential for impactful screening solutions, but could not be categorized as polymerase chain reaction (PCR), Isothermal Amplification, Next Generation Sequencing, or Antigen Detection and could not be tested through the competition rounds. 

The four winning teams in the Open Innovation Track are: 

Steradian Technologies, Inc.

Houston, United States

U-smell-it

Guilford, United States

Ram Global

Zweibrücken, Germany

TeraGroup

Herzliya, Israel

Meet the Finalists

Out of 219 teams, these remaining teams have demonstrated capabilities to develop Covid-19 tests for screening that are radically affordable compared to what is currently available on the market, that are comparable to commercial offerings at measuring sensitivity, specificity and limit of detection, with a maximum turnaround time of 12 hours from sample to result. Just one COVID-19 test option is not enough to meet society’s daily demands. XPRIZE Rapid Covid Testing recognizes the need for multiple testing solutions, awarding prizes to innovations in different categories — PCR, Isothermal Amplification, Next Generation Sequencing, and Antigen Detection. The diversification of testing options will help enable safe return to school and work, faster. 

Meet the Open Innovation Teams

Additionally, 10 other teams were selected to advance in the Open Innovation Track, whose approaches demonstrated high potential for impactful screening solutions, but could not be categorized as polymerase chain reaction (PCR), Isothermal Amplification, Next Generation Sequencing, or Antigen Detection and could not be tested through the competition rounds. At the discretion of the judging panel, top teams in this track will be eligible to win a share of $500,000. These teams may choose to perform testing at a deployment site and upon successful completion are eligible to share an additional award of up to $500,000.